anti-A-CHO response upon subsequent challenge with Strep.A, suggesting that induction of specific immunity had occurred.
Employing both these idiotypic systems for the in vitro analysis of lymphocytes primed with anti-Id, we investigated the specificity and the heterogeneity of Id-bearing T and B cells, as well as several possible objections raised against the interpretation of our previous in vivo experiments (1) . The results suggest: (a) Antigen contamination is not responsible for the sensitization of lymphocytes with anti-Id. (b) Anti-Id produced against a myeloma protein sensitizes T-helper cells as effectively as does anti-Id against an induced antibody. This eliminates a possible role of antibodies to T-cell receptors in T-cell sensitization. (c) T and B lymphocytes primed with the same anti-Id possess specificity for the same carbohydrate determinant. (d) The restriction in the heterogeneity of the lymphocyte populations primed with anti-Id, as compared to that of lymphocytes primed with Strep.A, is similar for T and B cells. A brief account of these experiments has been previously published (10) . Taken together, these data strongly suggest that the antigen recognition systems of B-and T-helper cells are alike with respect to heterogeneity, specificity, and idiotypic determinants. In the accompanying paper (11), we will present evidence that the same genes may participate in the coding for T-and B-cell receptor variable (V) regions.
Materials and Methods
Animals. 6-to 8-wk-old A/J mice were purchased from The Jackson Laboratory, Bar Harbor, Maine; and BALB/c mice were obtained from Zentralinstitut fitr Versuchstierzucht, Hannover, West Germany. All animals were vaccinated against ectromelia and rested at least 4 wk before being used in experiments. Guinea pigs were obtained from a local breeder.
Antigens. Sheep erythrocytes (SRBC) were purchased from Behringwerke, Marburg-Lahn, West Germany. Haptenation of SRBC with 2,4,6-trinitrobenzene sulfonic acid (TNBS) was performed by the method of Rittenberg and Pratt (12) . The preparation of the stearoyl derivative of A-CHO and its coupling to SRBC were done by the method of Pavlovskis and Slade (13) . Purified A-CHO and Group C streptococcal carbohydrate (C-CHO) were a gift from Dr. R. M. Krause, The Rockefeller University, New York.
Group A streptococci, strain JI7A4, were also a gift from Dr. R. M. Krause and the preparation of the vaccine (Strep.A) was done as previously described (14) . The haptenation of Group A streptococci with TNBS was achieved by a modification of the Rittenberg and Pratt technique (12) . A 200 mg portion of TNBS was dissolved in 42 ml of cacodylate buffer. 10 ml of cacodylate buffer containing 1.5 )< 1011 Strep.A particles were added under rapid mixing and the suspension was then stirred slowly at room temperature for 30 rain. Coupled particles (TNP-Strep.A) were centrifuged for 10 min at 300 g, the supernate was decanted and replaced by 30 ml of cacodylate buffer containing 50 mg of glycyl-glycine. The particles were resuspended, centrifuged, and the supernate decanted as before. This procedure was followed by four washes in 50 ml of 0.15 M saline. The haptenation reaction was conducted sterilely in foil wrapped glass vessels.
Idiotypes and Anti-Idiotypic Antibodies. The preparation of antibody A5A from the sera of irradiated A/J mice reconstituted with cloned spleen cells has been described (2) . Anti-Id antibodies to antibody A5A were prepared in guinea pigs and fractionated into their IgG1 and IgG2 classes by previously described methods (2, 3) . The Sl17 myeloma protein was isolated from the sera or ascites of mice bearing myeloma tumor S117, usingp-amino-phenyl-N-acetyl-glucosamine coupled to Sepharose 2B as an immunoadsorbent (15, 16) . Anti-Id antibodies to Sl17 and their IgG1 and IgG2 fractions were prepared as described for antisera to ASA (2, 3) , except that the anti-S117 sera were adsorbed on Sepharose 2B-coupled IgA/k myeloma proteins TEPC15 and J539. Details on the Sl17 idiotypic system will be published elsewhere. 2 The Id-binding capacity (IBC) of anti-Id sera and of IgG fractions purified from them was determined at 10 -8 M radioiodinated Id as previously described (4) .
Immunization. Priming was done by intraperitoneal injection of 1 x 10 v Strep.A organisms or 0.1 /~g IBC of anti-A5A Idl, which was found as effective as the intravenous injections used previously (1) . Except for a few experiments in which two priming injections were given at a 2 wk interval, a single injection was found satisfactory for both Strep.A and anti-A5A Idl. Priming with anti-S117 Idl was done as with anti-A5A Idl. To induce SRBC priming, 10 s erythrocytes were injected intraperitoneally. Mice immunized with anti-A5A Idl, anti-S117 Idl, or Strep.A were rested at least 4 wk before being used in experiments. Mice immunized with SRBC were used 9 days later for culture experiments.
Cell Preparations. Mice were killed by cervical dislocation and their spleens were removed sterily and immersed in cold sterile balanced salt solution (BSS). The spleens were then disrupted by teasing and the cell suspensions were allowed to sediment on ice. After 10 min, supernates were separated from sedimented cell debris, centrifuged, and the cell pellets were resuspended and washed in BSS.
Enriched T-cell preparations (85-95% Thy 1.2 positive) were obtained by passage of spleen cells through nylon wool columns according to the method of Julius et al. (17) . Spleen cells were depleted of T lymphocytes by treatment with an AKR anti-CBA anti-Thy 1.2 serum and agaroseabsorbed (18) guinea pig complement. The characteristics of the anti-Thy 1.2 serum and the methods for T-cell depletion have been described (19) . The viability of treated cells was examined by trypan blue exclusion to determine the efficency of specific killing. Then the cells were centrifuged and washed three times in BSS before use in culture experiments.
Lymphocyte Microculture. Lymphocyte microcultures were performed in Micro-Test II tissue culture trays (no. 3040; Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) using a modification of the Mishell and Dutton technique (20) . The culture medium, nutritional cocktail, and gas mixture were the same as used in the standard macroculture system (20) . Individual wells of a Micro-Test II tissue culture tray were seeded as follows: Antigen was added in 50 ~1 of medium, followed by 50 /~1 of medium containing 10 e spleen cells. For inhibition experiments the 50 pl of cells were added first and subsequently the inhibitor was added in 10 pl of medium. The mixtures were incubated at room temperature for 20 min. Then antigen, in 50 ~1 of medium, was added.
Inhibition experiments employed purified A-CHO and C-CHO, as well as anti-idiotypic antisera and normal guinea pig serum (NGPS) as control. All guinea pig sera were absorbed twice with 10% (vol/vol) normal spleen cells for 30 min at 4°C and centrifuged for 30 rain at 17,000 g before use. All inhibitors were present for the entire culture period.
Cultures were maintained without rocking at 37°C in a humid atmosphere of 10% CO2, 8% 02, and 82% N2, and were supplemented on each day with 10/~l of nutritional cocktail. After 4 days the Micro-Test II trays were centrifuged at 100 g for 10 rain. The culture medium was removed by suction and replaced with 100 ~tl of BSS. Each culture well was then assayed for direct and indirect plaque-forming cells (PFC) using the local hemolysis in gel assay.
Local Hemolysis in Gel Assay. Antibody-secreting cells were detected by the plaque assay of Jerne et al. (21) as modified by Mishell and Dutton (20) , using either A-CHO-SRBC or TNP-SRBC, or both. Attempts were made to detect IgG PFC according to the method of Dresser and Wortis (22) using as developing serum a rabbit antimouse Ig serum of proven ability. There were no anti-TNP IgG-secreting PFC detected in our cultures and we also consistently failed to detect indirect PFC specific for A-CHO even though such cells would have been expected to be generated in culture. This observation agrees with findings of other workers (23, 24) . Thus, only the number of direct PFC are presented in this paper. The specificity of PFC was ascertained by plaquing against uncoupled SRBC or by addition of various inhibitors including TNP-bovine serum albumin, A-CHO, or anti-ld, to the agarose gel. for the in vitro challenge with Strep.A (upper frame) and TNP-Strep.A (lower frame), respectively. Spleen cells from normal A/J mice and from A/J mice that had received two intraperitoneal injections of i × 10 s Strep.A particles or two intraperitoneal injections of 0.1 /~g IBC of anti-A5A Idl, respectively, were analyzed in these experiments. As can be seen from the dose-response curves in Fig. 1 , cells from mice primed with Strep.A and with anti-A5A Idl produced substantial numbers of PFC to A-CHO as well as to TNP when challenged in vitro with the appropriate antigen. Spleen cells from unprimed mice failed to respond to either antigen at any of the antigen concentrations tested. The data clearly show that priming with anti-A5A Idl generates precursor cells for a PFC response to A-CHO as well as helper activity for the response to a hapten that is coupled to Strep.A. Priming with anti-Id is at least as effective as priming with Strep.A. It is apparent that the optimal particle concentration for the induction of anti-TNP PFC is an order of magnitude greater than that for the induction of anti-A-CHO PFC. Similarly, cultures stimulated with TNP-Strep.A for an optimal anti-TNP PFC response produced hardly any anti-A-CHO PFC (data not shown). Therefore, precursor and helper activity were analyzed in separate experiments throughout this study.
Results

Precursor and Helper
In order to verify that helper function was indeed exerted by T lymphocytes, normal, Strep. A-, or anti-A5A Idl-primed spleen cells were treated either with normal mouse serum and complement or with anti-Thy-l.2 serum and complement before being exposed to TNP-Strep.A in culture. The results from a representative experiment are presented in Table I . Treatment with anti-Thy-1.2 serum and complement completely abolished the ability of all spleen cell preparations to generate TNP-specific PFC on challenge with TNP-Strep.A. Normal mouse serum and complement had little effect on this response. A more direct demonstration that T lymphocytes acted as helper cells in our culture system came from experiments in which nylon wool-enriched T lymphocytes were used. In order to substitute for B cells, untreated spleen cells or anti-Thy-1.2 and complement-treated spleen cells from normal mice were added to the cultures. Control cultures contained normal spleen cells, unfractionated primed spleen cells, or nylon wool-enriched T cells alone. A typical result is presented in Table II positive PFC, whereas anti-A5A Idl-primed cells invariably generated more than 90% A5A-positive PFC. It thus seems that immunization with anti-A5A Idl can drastically expand the A5A-positive PFC precursor pool. These data are in strict accordance with that obtained in vivo (1).
To study the specificity and heterogeneity of helper T cells, Strep.A-and anti-A5A Idl-primed spleen cells were challenged in vitro with TNP-Strep.A and analyzed for TNP-specific PFC. Inhibition experiments analogous to those performed to study B-cell specificity were done, but now the inhibitors were included into the culture medium in order to inhibit helper activity. Cultures in which inhibitions were performed were inoculated with: 0.1 or 0.01 ~g of A-CHO or of non-cross-reactive C-CHO, or with 0.1, 0.05, or 0.01 ~g IBC of anti-A5A serum or with equivalent dilutions of NGPS. The results from a typical experiment are presented in Table IV and are representative of those obtained in several separate trials.
The data show that neither of the primed helper cell populations was inhibited by C-CHO. In contrast, A-CHO, at both concentrations tested, had a strong inhibitory effect on the response of anti-A5A Idl-primed cells and, to a much lesser extent, on Strep.A-primed cells. A similar but more pronounced difference between Strep.A and anti-A5A Idl-primed helper cells was seen upon inhibition with anti-Id. Pronounced inhibition of anti-A5A Idl-primed helper cells is achieved with anti-A5A serum, whereas the effect of this antiserum on Strep.Aprimed helper cells was approximately 10 times less. The PFC numbers of cultures that had contained anti-Id have to be compared to that of the cultures with equivalent dilutions of NGPS. As can be seen, NGPS had a slight toxic effect on the cultures, which was, however, nonspecific and could be readily distinguished from the inhibitory effect of anti-Id. Not shown here are the results of~ontrol experiments in which the anti-A5A antiserum was tested for inhibition of the anti-TNP PFC response of SRBC-primed cells. No inhibition was found in these experiments, even with 0.1 ~g IBC of anti-A5A serum. The results in Table V Table VI .
It is apparent from the data that although helper cells were elicited in both strains by priming with Strep.A, only strain A/J produced helper cells in response to priming with anti-A5A Idl and only strain BALB/c produced helper cells in response to priming with anti-Sll7 Idl. Furthermore, the response of anti-A5A Idl-primed A/J cells was inhibited by addition of anti-ASA but not anti-Sll7 serum to the cultures. Conversely, the response of anti-Sll7 Idlprimed BALB/c spleen cells could be inhibited by addition of anti-Sll7 but not anti-A5A serum to the cultures. It is clear from the data that helper cell priming as well as inhibition of the helper function by anti-Id reveal the same idiotypic polymorphism as has been observed for the corresponding antibodies. Table I . $ The anti-A5A serum had an IBC of 250/xg/ml and the anti-S117 serum used had an IBC ml.
of 40 pg/ Discussion The present data confirm our previous observations (1) The present data extend the previous observations (1), mainly in two ways: (a) The in vitro system afforded a detailed analysis of the helper T-cell population that has not been possible in vivo, and (b) using the $117 idiotypic system as a counterpart to the A5A idiotypic system it was possible to rule out a number of trivial explanations for the stimulation of lymphocytes with anti-Id. These explanations included the suggestion that our anti-Id preparations were contaminated with antigen, that there exists a cross-reaction between idiotypic determinants of the anti-Id and some streptococcal antigen, and that our anti-Id antisera may contain antibodies to T-cell receptor molecules that may have been copurified with the original A5A antibody and, accordingly, were injected into the guinea pigs together with it. Whereas the former had been considered as rather remote possibilities (1), the latter was taken as a true alternative to account for T-cell activation by anti-Id. However, the experiments that employed the Id of myeloma protein $117 reveal that the anti-Id that interact with T cells are indeed directed against immunoglobulin idiotypes. Since an immunoglobulin secreted by a plasmacytoma tumor is not expected to contain any T-cellderived receptor molecules, the possibility of anti-T-ceU receptor antibodies contaminating the anti-Id antisera is ruled out at least for the $117 system. Furthermore, the strain specificity of lymphocyte sensitization by anti-Id completely eliminates the possibility of antigen contamination as well as the possible cross-reaction between the anti-Id and some streptococcal antigen.
The mechanism by which anti-Id sensitizes B and T lymphocytes is at this stage a matter of speculation. The association of the stimulatory capacity with the IgG1 fraction of anti-Id has been confirmed in unpublished experiments in which IgG2 fractions, isolated from the same sera, were found nonstimulatory at any of the doses (10 ng to 1 ~g IBC) at which stimulation was achieved with the IgG1 fractions. However, IgG1 fractions were found to contain small amounts (<1% of the total IBC) of IgM anti-Id, so that the stimulatory component may not be the IgG1 anti-Id itself. Thus, the requirements for lymphocyte stimulation by anti-Id are poorly understood. No doubt, however, exists that at some stage this process involves the binding of anti-Id to the antigen receptors on the lymphocyte surface. Whereas in the previously reported experiments (1) the specificity and heterogeneity of primed B cells could be studied by idiotypic analysis of antibody products, it was impossible to investigate equivalent properties of the primed helper cell population in vivo. This we have now done in vitro using classical carrier inhibition analysis to ascertain the specificity of T cells primed with antigen and with anti-Id. The results of these experiments clearly revealed that T-helper cells primed with Strep.A were heterogeneous in that only a fraction were inhibitable by A-CHO or anti-Id. This heterogeneity of Strep.A-primed helper cells is probably due to antigenic heterogeneity of the heat-killed and pepsin-treated streptococcus (14) which, in addition to the group-specific carbohydrate antigen, carries peptidoglycan and probably also residual proteins on its surface (25) . As immunization with Strep.A gives rise to antibodies against all of these antigens, it is not surprising that a similar spectrum of helper cell specificities is generated, and the partial inhibition of Strep.A-primed helper cells by A-CHO supports this view. The question whether there exists idiotypic heterogeneity within the A-CHO-specific portion of Strep.A-primed helper cells could not be answered beyond doubt, although the results of some experiments appeared to suggest that not all A-CHO-specific helper cells were inhibited by anti-Id. An idiotypic heterogeneity among helper T cells specific for one antigen would indicate the clonal distribution of idiotypes on T cells.
In contrast, helper cells primed with anti-Id were readily and equally well inhibited by anti-Id and A-CHO. This suggests that, out of a heterogeneous population of T-helper cells, anti-Id can identify and expand an apparently uniform cell population. The same was found to be the case for B cells, as shown in the previous paper (1) and confirmed by the present experiments (see Table  III ). The crucial question to be raised in this connection is whether the process of selecting a specific T-cell population resembles clonal selection as it occurs on the B-cell level. Although this is suggested by the existence of idiotypically uniform and monospecific T-cell populations, a definite answer to this question requires the demonstration that idiotypes are indeed c]ona] markers not only for B cells but also for T cells.
Another surprising finding which came from these studies is that T cells may have specificity for carbohydrate antigens. The experience of many laboratories that the immune responses to soluble polysaccharide antigens are T-cell independent may have led to the conclusion that T cells are unable to recognize polysaccharide determinants in general. This generalization has been disproved by our experiments. Moreover, T cells can distinguish between carbohydrate antigens as closely related as A-CHO and C-CHO, which are distinct by terminal hexosamines but possess the same rhamnose backbone (25, 26) . Thus, the discriminatory capacity of T cells with respect to these antigens is just as good as that of antibodies. This is in agreement with previous studies from this and other laboratories on helper cell specificity (27) (28) (29) .
The genetic analysis of T-and B-cell idiotypes will be discussed in detail in the accompanying paper (11) . In this context it may suffice to mention that both the ASA and Sl17 idiotypes have been assigned to the V region of the heavy chain of anti-A-CHO antibodies by means of their genetic linkage to the heavy-chain allotype (5, 6, 10) . The parallel expression of the same idiotypic polymorphism in both the B-and T-cell populations suggests that B-and T-cell idiotypes are governed by the same VH genes, and that the V region of the immunoglobulin H chain is shared between B-and T-cell antigen receptors. Our experiments have no bearing on any other part of the immunoglobulin molecule.
In addition to the sharing of idiotypes between B and T cells, the similarities in specificity and heterogeneity discussed above are further strong arguments in favor of the view that helper T cells use at least partially the same antigen recognition system as B cells, namely the products of H-chain V-region genes. Such conclusions are in agreement with recent experiments of Binz et al., which shown that antibody directed against a specific T-cell alloantigen recognition site also reacts with humoral alloantibody as well as with cells mediating graft vs. host reaction (30, 31) . Similarly, McKearn has shown that antialloantibody in rats inhibits graft rejection (32) . Binz and Wigzell, however, have also obtained evidence that Id-bearing molecules produced by T cells have properties that clearly distinguish them from immunoglobulin molecules (33) . Thus, it appears that evidence for the sharing of idiotypes between T-cell receptors and antibodies has now been obtained in several unrelated experimental systems. Future studies will be directed towards the isolation and characterization of Idbearing T-cell receptor molecules, using anti-Id as a probe.
